All data are based on the daily closing price as of May 12, 2026
s
Shinpoong Pharm
019170.KO
7.47 USD
-0.09
-1.19%
Overview
Last close
7.47 usd
Market cap
367.83M usd
52 week high
12.95 usd
52 week low
4.50 usd
Target price
3.87 usd
Valuation
P/E
N/A
Forward P/E
17.7305
Price/Sales
2.4312
Price/Book Value
2.1944
Enterprise Value
386.00M usd
EV/Revenue
2.4522
EV/EBITDA
25.5395
Key financials
Revenue TTM
157.41M usd
Gross Profit TTM
68.87M usd
EBITDA TTM
17.20M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
244.31M usd
Net debt
5.22M usd
About
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.